About Us
Coherent discovery through engineering
EMS Genomics merges engineering and biology to harness discovery in plants.
Single-celled and other plants have the ability to synthesize an almost limitless variety of natural compounds that are potentially of great value in the manufacture of break-through pharmaceuticals capable of treating a wide range of human diseases. Utilizing instrumentation of its own proprietary design for selectively stressing organisms, EMS Genomics has created both new technology and associated new methods for immediate quantification of stress levels.
Simply put, EMS Genomics is accelerating the discovery of plants with unique abilities that will provide the keys to new break-through pharmaceuticals.
We Create Solutions from Plants
Plants are rich in genetic targets for the development of pharmaceutical agents. We utilize several different scientific methodologies and technologies in our approach to creating more effective treatments. Specifically, we are involved in finding pharmaceutical targets within plants.
ABOUT THE FOUNDERS
EMS Genomics
The co-founders of EMS Genomics, LLC are Carl Staub, an electrical engineer with a long and productive career in instrument development and application, and Joseph Grzymski, Ph.D., a biophysics and microbiology professor specializing in advanced analytical approaches that address a wide range of fundamental and applied issues.
Mr. Staub
Mr. Staub has 30-years of experience developing innovative technologies and designing equipment in the fields of optics, spectroscopy, chemical detection, electronics, and solid-state lighting.
Dr. Grzymski
Dr. Grzymski is the Senior Director of the Applied Innovation Center and an Associate Research Professor of microbiology and computational biology at the Desert Research Institute (DRI) in Reno, Nevada.
WHERE GENOMICS AND NATURE MEET
EMS Genomics
Plants are powerful. We harness the power of plants to develop novel pharmaceutical applications to make medicine that saves lives.